SCM
THER

Soleus Capital Management’s THERATECHNOLOGIES INC COM THER Stock Holding History

Soleus Capital Management’s Portfolio THER Stock Details THER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,325,511
Closed -$7.85M – 126
2023
Q2 		$7.85M Buy
9,325,511
+235,000
+3% +$198K 0.87% 36
2023
Q1 		$7.36M Buy
9,090,511
+291,386
+3% +$236K 0.76% 39
2022
Q4 		$7.77M Buy
8,799,125
+791,411
+10% +$699K 1.11% 28
2022
Q3 		$19M Buy
8,007,714
+185,302
+2% +$439K 2.58% 15
2022
Q2 		$17.8M Buy
7,822,412
+130,330
+2% +$296K 2.77% 8
2022
Q1 		$18.8M Hold
7,692,082
– – 2.43% 13
2021
Q4 		$23.3M Buy
7,692,082
+79,699
+1% +$241K 2.33% 10
2021
Q3 		$28.5M Buy
7,612,383
+584,287
+8% +$2.19M 4.45% 5
2021
Q2 		$27.3M Buy
7,028,096
+76,749
+1% +$298K 4.19% 5
2021
Q1 		$26.9M Buy
+6,951,347
New +$26.9M 4.84% 3

Other funds holding THER

MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Soleus Capital Management's THER Position: Q3 2023 in Review

Soleus Capital Management sold out of THERATECHNOLOGIES INC COM (THER) in Q3 2023, closing a stake of 9,325,511 shares — an estimated $7.85M sold.

Soleus Capital Management first reported a position in THER in Q1 2021 and held it in 10 quarters. The position peaked at $28.5M in Q3 2021. 2 funds tracked by Wall St. Rank hold THER as of Q3 2023.

  • Soleus Capital Management reported no remaining THERATECHNOLOGIES INC COM position as of Q3 2023 after selling out during the quarter.
  • Soleus Capital Management sold 9,325,511 THERATECHNOLOGIES INC COM shares in Q3 2023, an estimated $7.85M.
  • Soleus Capital Management first reported a position in THERATECHNOLOGIES INC COM in Q1 2021 and held it in 10 quarters.
  • Soleus Capital Management's THERATECHNOLOGIES INC COM position peaked at $28.5M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q3 2023.

Based on Soleus Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.